Monopar Therapeutics
MNPR
#7537
Rank
S$0.60 B
Marketcap
S$89.01
Share price
-1.84%
Change (1 day)
-25.56%
Change (1 year)

EPS for Monopar Therapeutics (MNPR)

EPS in 2026 (TTM): S-$2.46

According to Monopar Therapeutics's latest financial reports the company's current EPS (TTM) is S-$2.46. In 2025 the company made an earnings per share (EPS) of S-$2.39 an increase over its 2024 EPS that were of S-$5.30.

EPS history for Monopar Therapeutics from 2016 to 2026

Annual EPS

Year EPS Change
2026 (TTM)S-$2.462.96%
2025S-$2.39-54.99%
2024S-$5.3035.2%
2023S-$3.92-26.75%
2022S-$5.3513.7%
2021S-$4.7125.86%
2020S-$3.7428.89%
2019S-$2.9045.28%
2018S-$2.00-80.5%
2017S-$10.251296.33%
2016S-$0.73

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
ORIC Pharmaceuticals
ORIC
S-$1.74-29.32%๐Ÿ‡บ๐Ÿ‡ธ USA